Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2015 1
2016 1
2017 6
2018 8
2019 10
2020 9
2021 11
2022 10
2023 9
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

61 results

Results by year

Filters applied: . Clear all
Page 1
Clinical utility of circulating tumor cells: an update.
Vasseur A, Kiavue N, Bidard FC, Pierga JY, Cabel L. Vasseur A, et al. Among authors: cabel l. Mol Oncol. 2021 Jun;15(6):1647-1666. doi: 10.1002/1878-0261.12869. Epub 2020 Dec 25. Mol Oncol. 2021. PMID: 33289351 Free PMC article. Review.
Efficacy of Circulating Tumor Cell Count-Driven vs Clinician-Driven First-line Therapy Choice in Hormone Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer: The STIC CTC Randomized Clinical Trial.
Bidard FC, Jacot W, Kiavue N, Dureau S, Kadi A, Brain E, Bachelot T, Bourgeois H, Gonçalves A, Ladoire S, Naman H, Dalenc F, Gligorov J, Espié M, Emile G, Ferrero JM, Loirat D, Frank S, Cabel L, Diéras V, Cayrefourcq L, Simondi C, Berger F, Alix-Panabières C, Pierga JY. Bidard FC, et al. Among authors: cabel l. JAMA Oncol. 2021 Jan 1;7(1):34-41. doi: 10.1001/jamaoncol.2020.5660. JAMA Oncol. 2021. PMID: 33151266 Free PMC article. Clinical Trial.
Invasive Lobular Carcinoma of the Breast: Toward Tailoring Therapy?
Djerroudi L, Cabel L, Bidard FC, Vincent-Salomon A. Djerroudi L, et al. Among authors: cabel l. J Natl Cancer Inst. 2022 Nov 14;114(11):1434-1436. doi: 10.1093/jnci/djac159. J Natl Cancer Inst. 2022. PMID: 36239762 No abstract available.
Circulating tumor cells: clinical validity and utility.
Cabel L, Proudhon C, Gortais H, Loirat D, Coussy F, Pierga JY, Bidard FC. Cabel L, et al. Int J Clin Oncol. 2017 Jun;22(3):421-430. doi: 10.1007/s10147-017-1105-2. Epub 2017 Feb 25. Int J Clin Oncol. 2017. PMID: 28238187 Review.
[Squamous cell anal carcinoma. What's next ?].
Kim S, Spehner L, Cabel L, Bidard FC, Borg C. Kim S, et al. Among authors: cabel l. Bull Cancer. 2021 Jan;108(1):80-89. doi: 10.1016/j.bulcan.2020.12.001. Epub 2021 Jan 8. Bull Cancer. 2021. PMID: 33423780 Review. French.
Microsatellite instability detection in breast cancer using drop-off droplet digital PCR.
Klouch KZ, Stern MH, Trabelsi-Grati O, Kiavue N, Cabel L, Silveira AB, Hego C, Rampanou A, Popova T, Bataillon G, Nasr S, Proudhon C, Michel M, Renault V, Masliah Planchon J, Vincent-Salomon A, Pierga JY, Bieche I, Renault S, Bidard FC. Klouch KZ, et al. Among authors: cabel l. Oncogene. 2022 Dec;41(49):5289-5297. doi: 10.1038/s41388-022-02504-6. Epub 2022 Nov 3. Oncogene. 2022. PMID: 36329125
Present and Future Research on Anal Squamous Cell Carcinoma.
Spehner L, Boustani J, Cabel L, Doyen J, Vienot A, Borg C, Kim S. Spehner L, et al. Among authors: cabel l. Cancers (Basel). 2021 Aug 2;13(15):3895. doi: 10.3390/cancers13153895. Cancers (Basel). 2021. PMID: 34359795 Free PMC article. Review.
ESR1 mutations: a new biomarker in breast cancer.
Carausu M, Bidard FC, Callens C, Melaabi S, Jeannot E, Pierga JY, Cabel L. Carausu M, et al. Among authors: cabel l. Expert Rev Mol Diagn. 2019 Jul;19(7):599-611. doi: 10.1080/14737159.2019.1631799. Epub 2019 Jun 19. Expert Rev Mol Diagn. 2019. PMID: 31188645 Review.
61 results